Data from patients who remained on tegoprubart for a year post transplant showed an overall mean 12-month estimated glomerular filtration rate (eGFR) of approximately 69 mL/min/1.73 m² ...
Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) (“Kiora” or the “Company”) today announced third quarter 2025 financial results and provided ...
President Donald Trump’s executive order halting penny production has triggered an urgent scramble across the retail sector.
An investigational triple agonist that targets fibroblast growth factor 21, glucagon and GLP-1 receptors cut triglyceride ...
Completed enrollment in Phase 2 LOTUS trial of AVTX-009 for the treatment of hidradenitis suppurativa; topline data expected mid-2026Appointed Kevin Lind to Board of DirectorsExpanded leadership team ...
Gyre Therapeutics ("Gyre") (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, ...
XRP struggles to stay above $2.15 after failing near $2.35. Analysts warn a drop below key support could trigger a deeper ...
Bitcoin price struggles to rally as a looming bearish cross warns of one last shakeout before recovery can begin.
Ended the third quarter with $380.5 million in cash, cash equivalents and short-term marketable debt securities which, together with funds from a previously announced debt-facility, are expected to pr ...
Roma made short work of Glasgow Rangers at Ibrox, as early Matias Soulé and Lorenzo Pellegrini goals locked down the ...
Solana inflows hit $9.7M in 24 hours as ETFs attract strong institutional demand, boosting bullish sentiment and fueling ...
XRP price hovers near $2.06 after a sharp correction. Bulls are buying the dip, but a looming death cross could decide what happens next.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback